Precautions for taking roflunomide: diarrhea, weight loss, psychiatric symptoms, and drug interactions
Roflumilast is used to reduce the risk of acute exacerbations of COPD. During medication, close attention should be paid to diarrhea, weight loss, psychiatric symptoms, and drug interactions, and these should be identified and managed promptly.
I. Diarrhea and Gastrointestinal Reactions
1. Common manifestations
Diarrhea is one of the most common adverse reactions of roflumilast.
It may be accompanied by nausea, abdominal pain, and loss of appetite.
Most cases are mild to moderate, and some patients may gradually develop tolerance.
2. Management recommendations
When diarrhea occurs, pay attention to replenishing water and electrolytes.
Avoid spicy, greasy, and irritating foods.
If diarrhea persists or worsens, seek medical attention promptly to assess whether dose adjustment is needed.
3. Situations requiring vigilance
Severe diarrhea leading to dehydration or electrolyte imbalance.
Diarrhea accompanied by obvious weight loss or general fatigue.
The above situations require prompt medical attention.
II. Weight Loss
1. Characteristics of occurrence
Roflumilast may cause weight loss, which can be relatively obvious in some patients.
It may be related to loss of appetite, diarrhea, and metabolic changes.
Low-body-weight patients are at higher risk.
2. Monitoring recommendations
Monitor body weight regularly during medication.
Record weight change trends, and inform the doctor if continuous decline is found.
If necessary, assess nutritional status and adjust the diet.
3. Management principles
If unexplained or obvious weight loss occurs, medical evaluation is needed.
The doctor may adjust the dose or discontinue the medication according to the situation.
Do not stop the medication or increase or decrease the dose on your own.
III. Psychiatric Symptoms and Drug Interactions
1. Psychiatric symptoms
May cause insomnia, anxiety, and low mood.
A small number of patients may experience worsening depression or suicidal thoughts.
Patients with a history of psychiatric disorders are at higher risk and require close monitoring.
If emotional abnormalities or suicidal thoughts occur, seek medical attention immediately.
2. Drug interactions
Strong CYP450 enzyme inducers (such as rifampin) may reduce the efficacy of roflumilast.
Strong CYP450 enzyme inhibitors (such as ketoconazole) may increase its exposure and the risk of adverse reactions.
Concomitant use with contraceptives containing gestodene may increase progestogen exposure.
3. Medication reminders
Inform the doctor of all concomitant medications before medication.
Avoid using other drugs or health supplements on your own.
Maintain regular follow-up during treatment, and seek medical attention promptly if abnormalities occur.
Disclaimer：《Precautions for taking roflunomide: diarrhea, weight loss, psychiatric symptoms, and drug interactions》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！